Adaptation and validation of the Dutch version of the nasal obstruction symptom evaluation (NOSE) scale by Van Zijl, F.V.W.J. et al.
Vol.:(0123456789) 
Eur Arch Otorhinolaryngol 
DOI 10.1007/s00405-017-4486-y
RHINOLOGY
Adaptation and validation of the Dutch version of the nasal 
obstruction symptom evaluation (NOSE) scale
Floris V. W. J. van Zijl1 · Reinier Timman2 · Frank R. Datema1 
Received: 4 January 2017 / Accepted: 25 January 2017 
© The Author(s) 2017. This article is published with open access at Springerlink.com
(NL-NOSE) demonstrated satisfactory reliability and valid-
ity. We recommend the use of the NL-NOSE as a validated 
instrument to measure subjective severity of nasal obstruc-
tion in Dutch adult patients.
Keywords NOSE scale · Quality of life · Nasal 
obstruction · Validation · Dutch language
Introduction
In 2004, Stewart et  al. introduced the nasal obstruction 
symptom evaluation (NOSE) scale as a valid, reliable, and 
responsive self-report instrument to quantify the subjective 
burden related to nasal obstruction [1]. Patients are asked 
to answer five 5-point Likert Scale questions related to 
nasal obstruction resulting in a sumscore, ranging from 0 to 
20, which is then multiplied by 5. The instrument is easy to 
complete with a minimal respondent burden, likely contrib-
uting to its global popularity in outcome research and sur-
gical technique evaluation. This is illustrated by validated 
adaptations of the NOSE scale for the Spanish, Chinese, 
Italian, French, Greek, and Portuguese language [2–7]. 
Additionally, normative and abnormal value ranges for the 
NOSE scale have been outlined, allowing a more precise 
definition of treatment success and meaningful clinical 
changes of numerical scores [8]. The primary aim of this 
study was to translate and validate the NOSE scale instru-
ment into the Dutch language.
An important remark when using (extensive) question-
naires to evaluate patient satisfaction, quality of life and 
change herein following medical treatment, is the influence 
of ‘respondent burden bias’ on given answers when ques-
tionnaires are too extensive. Although the NOSE scale is a 
relatively short questionnaire with only five items, the risk 
Abstract The nasal obstruction symptom evaluation 
(NOSE) scale is a validated disease-specific, self-com-
pleted questionnaire for the assessment of quality of life 
related to nasal obstruction. The aim of this study was to 
validate the Dutch (NL-NOSE) questionnaire. A prospec-
tive instrument validation study was performed in a tertiary 
academic referral center. Guidelines for the cross-cultural 
adaptation process from the original English language 
scale into a Dutch language version were followed. Patients 
undergoing functional septoplasty or septorhinoplasty and 
asymptomatic controls completed the questionnaire both 
before and 3  months after surgery to test reliability and 
validity. Additionally, we explored the possibility to reduce 
the NOSE scale even further using graded response mod-
els. 129 patients and 50 controls were included. Internal 
consistency (Cronbach’s alpha 0.82) and test–retest reliabil-
ity (intraclass correlation coefficient 0.89) were good. The 
instrument showed excellent between-group discrimina-
tion (Mann–Whitney U = 85, p < 0.001) and high response 
sensitivity to change (Wilcoxon rank p < 0.001). The NL-
NOSE correlated well with the score on a visual analog 
scale measuring the subjective sensation of nasal obstruc-
tion, with exception of item 4 (trouble sleeping). Item 4 
provided the least information to the total scale and item 
3 (trouble breathing through nose) the most, particularly in 
the postoperative group. The Dutch version of the NOSE 
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of inaccurate or incomplete answers might become impor-
tant when the NOSE scale is offered to patients in addition 
to other questionnaires used for routine outcome monitor-
ing (ROM). The secondary aim of this study was therefore 
to explore the possibility to reduce the NOSE scale into a 
more concise version including only the most indicative 
items.
Materials and methods
This single-center instrument validation study consisted of 
a cross-cultural adaptation phase and a statistical validation 
phase. All data were prospectively collected between April 
1, 2015 and September 1, 2016 at the department of otorhi-
nolaryngology and head and neck surgery, and the depart-
ment of urology of the academic Erasmus Medical Center, 
Rotterdam (the Netherlands). This study was approved by 
the Medical Ethics Committee of the Erasmus Medical 
Center, Rotterdam, the Netherlands, documented by Study 
Number MEC-2015-361.
Phase 1: cross‑cultural adaptation to the Dutch 
language
General accepted guidelines for the process of cross-cul-
tural adaptation were followed [9]. Forward translation of 
the original NOSE questionnaire was performed by one 
bilingual Dutch-native otolaryngologist and one bilingual 
Dutch-native professional translator without medical back-
ground. The two bilingual investigators reconciled differ-
ences between the two forward translations and checked 
for semantic and conceptual equivalence, resulting in one 
single provisional Dutch translation of the NOSE scale. 
Two English-native translators without medical back-
ground then translated the provisional Dutch questionnaire 
back into the original language. These backward transla-
tions were compared with the original NOSE scale focus-
ing on discrepancies and item content. The end result was a 
final version of the questionnaire (NL-NOSE, Fig. 1).
Phase 2: NL‑NOSE validation
Study populations
For this study, two separate populations were recruited 
prospectively. The first group included patients with nasal 
obstruction caused by a septal deviation and/or nasal valve 
insufficiencies. Patients were included when they were 
eligible for surgery, able to speak and read the Dutch lan-
guage, and experienced nasal obstruction longer than 
3 months, without a noticeable response to intranasal ster-
oid treatment for a minimum of 4  weeks. We excluded 
patients younger than 18 years, patients with nasal obstruc-
tion related to mucosal disorders, craniofacial patients, or 
patients who had prior septoplasty/septorhinoplasty or 
turbinate surgery. The second group consisted of healthy 
asymptomatic controls recruited at the department of urol-
ogy. Controls needed to be older than 18 years, be able to 
read and speak the Dutch language, and have no history of 
nasal obstruction and/or use of intranasal medication.
Methods and statistical analysis
Generally accepted quality criteria for validation were used 
as a guideline [10, 11]. Generally, in the various language 
Fig. 1  NL-NOSE adapted from the original NOSE scale (italic)
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NOSE validation studies, correlations of at least 0.40 with 
criterion measures were reported [2–6]. In order to detect a 
significant correlation coefficient of at least 0.40, we con-
sidered 50 cases as sufficient [12]. In cases where one out 
of five NL-NOSE items was missing, the total score was 
calculated from the mean of the completed items. If more 
than one item was missing, the case was excluded.
Internal consistency
Internal consistency was investigated using Cronbach’s 
alpha coefficient, which was considered fair when alpha 
was between 0.70 and 0.79, good between 0.80 and 0.89, 
and excellent above 0.90 [13]. Corrected item-total and 
inter-item correlations were tested using Spearman correla-
tions. For assessment of unidimensionality, a confirmatory 
factor analysis (CFA) was performed in the preoperative, 
postoperative, and control groups. These CFAs tested sin-
gle-factor models without allowing additional covariances 
between the items. All CFAs were applied using ordinary 
maximum likelihood that excludes cases with missing val-
ues. Standards for a good fit were derived from Brown [14]. 
The recommended index values are presented in Table 2.
Reproducibility
Test–retest reliability was investigated by administering 
a second NL-NOSE questionnaire 2  weeks after the first. 
This was carried out for the patient group only. Patients 
with any change in conservative treatment after completing 
the first questionnaire (medication, nasal steroids, other) or 
change of symptoms due to upper or lower airway infec-
tions were excluded for the assessment of test–retest reli-
ability. Test–retest reliability was calculated using 2-way 
random average measures intraclass correlation coefficients 
(ICC), with a positive rating for reliability given at >0.70. 
Differences between responders and non-responders at the 
second test were analyzed with Mann–Whitney U tests and 
a χ2 test.
Discriminant validity
Discriminant validity of the NL-NOSE was tested by com-
parison of the scores of the patient group with the asymp-
tomatic control group with a Mann–Whitney U test, with a 
significant difference defined as p < 0.05.
Responsiveness
The response (sensitivity to change) was tested using a 
subgroup of patients who were asked to complete the NL-
NOSE 3 months after surgery, assessed with the Wilcoxon 
rank test and calculation of the mean and inter-quartile 
range.
Construct validity
In the absence of an objective gold standard to quan-
tify nasal patency, construct validity was assessed with a 
Spearman correlation test between NL-NOSE item scores 
and scores on a 100  mm Visual Analog Scale indicat-
ing nasal airway patency, ranging from 0 (very bad) to 10 
(very good). Our predefined hypothesis reads “patients 
with higher NL-NOSE scores, indicating more subjective 
burden of nasal obstruction, will have higher scores on the 
nasal airway patency VAS.”
Graded response models
Although this study was not primarily set up to develop 
a shorter version of the NL-NOSE scale, an exploratory 
attempt was made to reduce the number of items. For this 
purpose, graded response models (GRMs) were fitted to 
assess the information provided by each individual item 
on the latent trait. We only utilized the samples for which 
the unidimensionality assumption was reasonably met. The 
likelihood method applied in these GRMs was mean and 
variance adaptive Gauss–Hermite quadrature.
CFA was performed with STATA version14.1 (Stata-
Corp, College Station, TX 77845 USA); all other statisti-
cal analyses were performed with SPSS 21.0 (IBM SPSS, 
Armonk, NY, USA).
Results
Based on inclusion and exclusion criteria, a total of 131 
patients with an indication for functional septoplasty or 
septorhinoplasty and 51 asymptomatic controls completed 
the NL-NOSE questionnaire. 129 patients and 50 con-
trols gave valid answers on at least 4 items. Of these 129 
patients, 77 completed an additional retest questionnaire 
returned by postal mail, 47 did not respond, and 5 were 
excluded for retest analysis due to an unintended change in 
conservative treatment. No significant baseline differences 
were observed between responders and non-responders for 
the total NOSE scale (Mann–Whitney U = 1950, p = 0.80), 
age (U = 1925, p = 0.71), and gender (χ2 = 0.043, p = 0.84). 
On November 1, 2016, 64 out of 129 patients were oper-
ated on, of whom 50 patients had sufficient follow-up 
time to complete an additional postoperative question-
naire 3 months after surgery. A total of 313 administrations 
had been performed, with a total of 13 missing values on 
individual items (0.83%). These missing values led to the 
exclusion of four cases (1.28%).
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The patient population (N = 129) consisted of 82 males 
(63.6%), with a mean age of 34.6 ± 14.5 (range 17–74). 
Mean sumscore (0–100) was 70.5 ± 20.0 (SD). No signifi-
cant correlations of the NL-NOSE with age were observed, 
and there were no significant differences between men and 
women (non-parametric tests, all p values >0.30).
Internal consistency
Internal consistency of the NL-NOSE was high with 
a Cronbach’s alpha of 0.81 for the preoperative group 
(N = 129), and 0.91 in the postoperative group (N = 50). 
Item-total and inter-item correlations for both preopera-
tive and postoperative measures are displayed in Table 1. In 
the preoperative group, all values were above 0.40 except 
for the correlation between items ‘trouble sleeping’ and 
‘nasal blockage or obstruction’ (0.36), and the correlation 
between items ‘trouble sleeping’ and ‘unable to get enough 
air through my nose during exercise’ (0.32). The inter-item 
correlations within the control group were much lower, in 
particular for item 5, while the inter-item correlations for 
all participants combined were much higher. Relationships 
between the different variables were close with highly sig-
nificant differences (p < 0.01) for all correlations.
The confirmatory factor analysis in the preoperative 
group showed good indices for the CFI, TLI, and SRMR, 
but a lesser value for the RMSEA, although the chance 
that the RMSEA (pclose) is not significant is acceptable 
(Table 2, abbreviations enlisted), generally indicating that 
the unidimensionality assumption is reasonably met. In 
the postoperative group, all fit indices are excellent. The fit 
measures in the control group are poor, indicating that uni-
dimensionality of the scale in this group is not satisfactorily 
established.
Reproducibility
Test–retest reliability (N = 77) was good with an intraclass 
correlation of 0.89 (p > 0.001).
Table 1  Inter-item and 
corrected item-total Spearman 
correlations of NL-NOSE
Item
1. 
Congestion
2. 
Obstruction
3.
Breathing
4.
Sleeping
5.
Exercise
Corrected 
total
1. Congestion 0.72 0.81 0.51 0.80 0.84 Postoperative
2. Obstruction 0.61 0.77 0.46 0.69 0.77
3. Breathing 0.52 0.57 0.55 0.81 0.89
4. Sleeping 0.52 0.36 0.49 0.53 0.56
5. Exercise 0.48 0.46 0.54 0.32 0.86
Corrected total 0.69 0.60 0.67 0.53 0.54
Preoperative
1. Congestion 0.81 0.78 0.70 0.73 0.84 All participants
2. Obstruction 0.43 0.80 0.65 0.73 0.82
3. Breathing 0.46 0.45 0.73 0.81 0.87
4. Sleeping 0.33 0.33 0.35 0.94 0.74
5. Exercise 0.14 0.31 0.54 0.16 0.79
Corrected total 0.44 0.74 0.77 0.75 .084
Controls
Table 2  Fit measures and 
confirmatory one-factor analysis
RMSEA root mean square error of approximation, pclose probability of RMSEA ≤0.05, CFI comparative fit 
index, TLI Tucker–Lewis index, SRMR standardized root mean squared residual
*<0.05 = good, <0.08 reasonable
Preoperative, 
N = 126
Postoperative, 
N = 50
Control, N = 50 All cases, 
N = 303
Recom-
mended, 
Brown [14]
RMSEA 0.103 0.024 0.208 0.115 <0.05/<0.08*
pclose 0.112 0.471 0.015 0.008 >0.05
CFI 0.968 0.999 0.876 0.985 >0.95
TLI 0.935 0.998 0.752 0.971 >0.95
SRMR 0.033 0.022 0.070 0.014 <0.08
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Control group and discriminant validity
In the control group (N = 50), nineteen (38.0%) controls 
were male and the average age was 47.9 ± 16.8 (range 
19–80). Mean sumscore was 8.5 with a standard devia-
tion of 13.0 (Fig. 2). The NL-NOSE showed excellent dis-
crimination between groups with a mean rank of 114.3 for 
patients and a mean rank of 27.2 for controls (Mann–Whit-
ney U = 85, p < 0.001). Cronbach’s alpha in the control 
group was 0.79.
Pre‑ and postoperative evaluation (responsiveness)
Patients that completed a questionnaire before and after 
surgery (N = 50) were all operated on by one author (FRD), 
performing either a septoplasty or (septo)rhinoplasty 
mainly aiming at restoring nasal patency. Postoperative 
mean sumscores were significantly lower compared to pre-
operative values (Wilcoxon rank p < 0.001). All but two 
patients had lower scores after the operation; these two 
patients reported no change. The magnitude of surgery 
effect was large; median sumscores dropped from 70.0 pre-
operatively to 20.0 postoperatively (median change 40.0, 
inter-quartile range 25–63).
Correlation with VAS (construct validity)
Correlation of the mean VAS score (left and right) with 
the NL-NOSE sum score and individual items is shown in 
Table 3. Sum scores correlated well with the VAS, both for 
the symptomatic cohort pre- and postoperatively and for 
the control cohort, confirming our hypothesis. Regarding 
the individual items, only the item ‘trouble sleeping’ did 
not correlate well with VAS.
Graded response models
We fitted in GRMs for the pre- and postoperative patients, 
as the unidimensionality assumption was reasonably met in 
these groups. It must be noted that these models are explor-
ative, as Reise and Yu reported that a GRM can be esti-
mated with 250 cases but a sample of at least 500 is advised 
[15]. Our preoperative group included only 131 cases for 
this analysis, and the postoperative group 51. In both sam-
ples, item 4 (trouble with sleeping) provided the least infor-
mation to the total scale and item 3 the most, particularly 
in the postoperative group (Table 4; Fig. 3). These findings 
are confirmed with classical test theory CTT analyses; the 
Mann–Whitney U values are the largest for item 4 and the 
smallest for item 3 (Table 4). Mann–Whitney Z-values are 
Fig. 2  Sum scores of patients 
and controls
Table 3  Spearman correlations 
of NL-NOSE with VAS
rho Spearman correlation
Item Preoperative, N = 129 Postoperative, N = 50 Control, N = 50
rho p rho p rho p
1. Congestion 0.46 <0.001 0.66 <0.001 0.57 <0.001
2. Obstruction 0.43 <0.001 0.79 <0.001 0.50 <0.001
3. Breathing 0.40 <0.001 0.74 <0.001 0.45 0.001
4. Sleeping 0.12 0.165 0.36 0.002 0.20 0.169
5. Exercise 0.46 <0.001 0.67 <0.001 0.36 0.011
Total 0.44 <0.001 0.78 <0.001 0.65 <0.001
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the largest for item 3. These values for item 3 are about as 
large as for the total scale, suggesting that the total scale 
might not provide much more information than item 3.
Discussion
Routine outcome measuring has become an important 
indicator for medical performance. Transparent outcome 
reports assist the patient in making an educated guess 
between health care providers as long as the instruments 
used are comparable. The use of patient-reported outcome 
measures, in the absence of globally accepted objective 
instruments, is feasible when the instruments used are vali-
dated. The NOSE scale is a validated, globally accepted 
instrument to quantify the burden related to nasal obstruc-
tion and change herein following nasal surgery. Cross-
cultural adaptation of the NOSE scale makes it a valuable 
instrument allowing the comparison of outcome results 
between institutions and to organize multi-center studies. In 
that context, our need for a validated Dutch version of the 
NOSE scale became apparent.
Internal consistency measures the extent to which items 
in a questionnaire are correlated, which is an important 
measurement property for questionnaires that intend to 
measure a single underlying concept using multiple items 
such as the NOSE questionnaire [10]. We found a Cron-
bach’s alpha of 0.81 for the NL-NOSE, which is within 
accepted ranges and comparable to previously reported 
NOSE validation studies [1–5, 7]. When looking at the 
Cronbach’s alpha of the postoperative cohort, we found a 
value of 0.91. This is also reflected by Table 1, displaying 
that item correlations in the postoperative group are higher 
compared to the correlations of the preoperative group, and 
in Table 2 that the fit for a unidimensional model is better 
for the postoperative group.
The reproducibility of the NL-NOSE was confirmed by 
performing a test–retest, correlating initial test and subse-
quent retest scores. We found an intraclass correlation coef-
ficient of 0.89, demonstrating that the questionnaire is sta-
ble over time. Normative data were generated by a cohort 
with no distinct complaints of nasal patency. This group 
scored a mean of 8.5 ± 13.0 compared to 70.5 ± 20.0 in the 
case cohort, suggesting that the NL-NOSE is a sensitive 
Table 4  GRM item discrimination coefficients and differences in total NOSE scores between groups
M-W Mann–Whitney U test
*All p values <0.001
GRM item coefficient (95% CI) Difference, pre- and postoperative Difference, preoperative and 
controls
Preoperative, N = 131 Postoperative, N = 51 M-W, U value M-W*, Z value M-W U value M-W*, Z value
1. Congestion 2.51 (1.55, 3.47) 3.87 (1.92, 5.81) 1102.0 7.09 317.5 9.63
2. Obstruction 2.26 (1.46, 3.06) 3.46 (1.70, 5.22) 938.0 7.50 364.0 9.44
3. Breathing 2.60 (1.56, 3.63) 8.80 (−1.50, 19.11) 807.5 8.07 150.0 10.18
4. Sleeping 1.33 (0.83, 1.84) 1.69 (0.70, 2.68) 1095.0 7.20 597.0 8.78
5. Exercise 1.82 (1.15, 2.49) 4.57 (2.09, 7.04) 116.0 7.15 241.0 9.10
Total 670.0 8.23 85.0 10.12
Fig. 3  GRM item information functions for pre- and postoperative patients
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instrument to identify patients with nasal patency com-
plaints. The correlations between the VAS and the total 
score of the NL-NOSE demonstrated good construct valid-
ity. We explored pre-, postoperative, and control group 
correlations, and found that the correlations with VAS in 
these separate patient groups were lower compared to the 
correlations documented in the Spanish and Italian valida-
tions studies [5, 6]. However, both the Spanish and Italian 
authors do not mention the composition of the group tested. 
When using the total cohort, we found higher correlations 
with VAS, comparable to those reported in the Italian 
study. These higher correlations are caused by the larger 
variance induced by the combination of low scoring con-
trols and postoperative patients and high scoring preopera-
tive patients for the total scale and their high respectively 
low VAS scores. Regarding the individual items, only the 
item ‘trouble sleeping’ did not correlate well with VAS, 
which is similar to the results of other validation studies. 
The GRM also pointed out that item 4 is not contributing 
very well to the total scale.
Perhaps most importantly, in line with other validation 
studies, the NL-NOSE demonstrated excellent responsive-
ness after surgery, indicating that the instrument is suit-
able for measuring treatment outcome. Median sumscores 
dropped from 70 to 20 after surgery, which is comparable 
to the systematic review of Rhee et  al. reviewing NOSE 
scores of patients with nasal airway obstruction after 
septo(rhino)plasty with or without turbinate surgery [8]. 
The authors compiled scores and found a mean pretreat-
ment score of 65 (standard deviation 22) and a mean post-
treatment score of 23 (20). Furthermore, the authors found 
that that no individual study dropped less than 30 points, 
suggesting that a change of at least 30 may be considered 
a clinically meaningful measure of surgical success. Our 
results, with a median decrease of 40 points after surgery, 
therefore, confirm that the NL-NOSE is able to measure 
clinically meaningful success of nasal functional surgery.
We fitted GRMs in order to explore whether a more con-
cise version of the NL-NOSE could be constructed. These 
models suggest that item 3 might be nearly as informative 
as the overall NL-NOSE sumscore. Future research pointed 
to this issue with larger study populations should be con-
ducted to reach more definite conclusions.
A potential shortcoming of the study may be that the 
proportion of men is larger in the patient group compared 
to the control group. However, as we found no relation of 
the NL-NOSE with gender, we consider the influence of 
this difference to be minimal. Second, due to the lack of a 
Dutch questionnaire measuring nasal patency-specific qual-
ity of life that has been validated in functional (septo)rhi-
noplasty patients, we had no perfect gold standard to com-
pare our results  to. Instead, we chose to compare results 
to a nasal patency VAS score, for which our predefined 
hypothesis was met. Lastly, this is a single-center study 
performed in an academic hospital, potentially causing 
impaired generalizability or selection bias. In the original 
validation study of Stewart, however, the NOSE question-
naire revealed good measurement properties in a multi-
center study with four academic hospitals, and Larrosa 
et al. included both a tertiary and regional center with com-
parable results [1, 6].
Conclusion
This study was performed to adapt the NOSE questionnaire 
to the Dutch language. Satisfactory internal consistency, 
reliability, reproducibility, validity, and responsiveness 
were demonstrated. We recommend the use of the NL-
NOSE to quantify the subjective burden related to nasal 
obstruction and change herein following surgical interven-
tion in Dutch adults.
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